Tag: Vaccine
-
New Super Flu Strain H3N2 Subclade K Spreads Globally, CDC Warns
Overview: A New H3N2 Subclade K Emerges The U.S. Centers for Disease Control and Prevention (CDC) has issued a stark alert about a newly mutated influenza A strain, identified as H3N2 subclade K. Described as fast-moving and increasingly dominant in multiple regions, the variant is prompting health officials to stress vigilance as the 2025-2026 flu…
-
Hepatitis B Vaccine Contract Sparks Ethics Concerns in Guinea-Bissau
Overview of the Contract The Trump administration has reportedly awarded a $1.6 million, no-bid contract to a Danish university to study hepatitis B vaccinations in newborns in Africa. Reports indicate the project focuses on administering Hepatitis B vaccines to infants in Guinea-Bissau, a West African country, with researchers hoping to gather data on safety, efficacy,…
-
ILS and IIT-Bhubaneswar Pioneer Next-Generation TB Subunit Vaccine Hsp16.3C4
Breakthrough in TB Research: A New Subunit Vaccine In a landmark collaboration, the Institute of Life Sciences (ILS) in Bhubaneswar and IIT-Bhubaneswar have announced the development of a next-generation subunit vaccine for tuberculosis (TB). The vaccine, named Hsp16.3C4, represents a significant step forward in the global effort to curb TB, which remains a major public…
-
Maine Experts Sound Alarm: Flu Season Could Be Stronger This Year
Public health cautions as flu strains diverge from the vaccine Maine health officials and researchers are sounding the alarm about what could be a tougher influenza season. A strain of the flu virus that isn’t a precise match for the current vaccine has been spreading in other regions, including the United Kingdom, Canada, and Japan,…
-
Canada braces for a tough flu season as evolving H3N2 strain challenges the vaccine
Canada Faces a Potentially Severe Flu Season Canada is preparing for what many experts are warning could be one of the worst influenza seasons in years. The concern centers on an evolving H3N2 strain that has been spreading globally and may not be a good match for this year’s vaccine. As flu cases rise, doctors…
-
SUM-101 Malaria Vaccine Shows Strong Immune Response
Overview of the SUM-101 Trial A new experimental malaria vaccine known as SUM-101 has generated hopeful results in its initial testing phase. Conducted among Tanzanian adults who have lived with malaria exposure, the early trial aimed to assess the vaccine’s safety and its ability to stimulate the immune system — a key step before larger…
-
Foot-and-Mouth Disease Vaccine Doses Now Available in SA
Overview In a move set to impact South Africa’s livestock sector, the Botswana Vaccine Institute (BVI) has made an additional 70,000 doses of the foot-and-mouth disease (FMD) vaccine available for purchase on the local market. The announcement was confirmed by Dewald Olivier, CEO of Red Meat Industry Services (RMIS), as part of ongoing efforts to…
-
Mpox Clade Ib Spreads in Europe: Why Vaccination Remains Key
Mpox Clade Ib: A new reminder for vaccination Health authorities in Europe are raising alarms as the mpox (monkeypox) landscape shifts with the emergence of clade Ib cases in several countries. While mpox has historically affected different populations, recent reporting shows small numbers of clade Ib infections in Portugal, Spain, Italy, the Netherlands, and the…
-
Triple-action vaccine shows promise against typhoid and invasive Salmonella in Phase 1 trial
New Phase 1 results offer hope for a dual-protection vaccine A novel trivalent vaccine designed to guard against both typhoid fever and invasive non-typhoidal Salmonella (iNTS) infections has demonstrated encouraging safety and immune responses in a Phase 1 human trial. The study, led by researchers from the University of Maryland (UM) School of Medicine in…
-
What Data TAG-CO-VAC Will Use for December 2025 COVID-19 Vaccine Antigen Decisions
Overview The World Health Organization’s Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) is preparing for its December 2025 decision-making meeting. The group continuously monitors the genetic and antigenic evolution of SARS-CoV-2 variants, immune responses following infection and vaccination, and the performance of currently authorized vaccines against circulating strains. The goal is to guide vaccine…